receptor-positive breast cancer

Receptor-positive breast cancer refers to tumors expressing estrogen, progesterone, or HER2 receptors, making them amenable to targeted therapies; compared to triple-negative breast cancer, receptor-positive types often exhibit different metabolic dependencies; studies suggest that these cancers may not utilize omega-6 linoleic acid as extensively, highlighting distinct molecular profiles among breast cancer subtypes.